https://biotechmorning.com/news/gsk-chimagen-750m-myeloma-deal Biotech Morning en 2026-09-15T14:15:17.511Z GSK Just Wrote a $750M Check for a Drug That Doesn't Exist Yet https://biotechmorning.com/news/moderna-mflusiva-mrna-flu-vaccine-fda-approval-2 Biotech Morning en 2026-09-15T14:14:31.058Z Moderna Just Proved mRNA Isn't a One-Hit Wonder https://biotechmorning.com/news/lilly-kills-obesity-drug-smart-move Biotech Morning en 2026-09-15T14:13:44.081Z Lilly Just Killed an Obesity Drug. That's Actually the Smart Move. https://biotechmorning.com/news/corbus-obesity-drug-cb1-novo-nordisk Biotech Morning en 2026-09-15T14:12:58.955Z The Obesity Drug That Worked Where Novo Nordisk Couldn't https://biotechmorning.com/news/biontech-gotistobart-doubles-survival-squamous-lung-cancer Biotech Morning en 2026-09-15T14:12:07.603Z BioNTech's Lung Cancer Drug Just Doubled What Chemo Could Do https://biotechmorning.com/news/fda-psychedelic-therapy-approval-hearing Biotech Morning en 2026-09-15T14:11:23.375Z The FDA Just Opened the Door to Prescribing Magic Mushrooms https://biotechmorning.com/news/novo-nordisk-walks-away-285m-ascendis-glp1-deal Biotech Morning en 2026-09-15T14:10:35.135Z Novo Nordisk Just Walked Away from a $285M Obesity Bet. Why? https://biotechmorning.com/news/jnj-contineum-depression-drug-phase-2-failure Biotech Morning en 2026-09-15T14:09:46.674Z J&J's Antidepressant Keeps Striking Out, and Nobody's Surprised https://biotechmorning.com/news/zipalertinib-egfr-exon20-lung-cancer-challenge Biotech Morning en 2026-09-14T14:19:03.003Z The Pill That's Coming for J&J's Lung Cancer Throne https://biotechmorning.com/news/electra-therapeutics-billion-dollar-ipo-sirp Biotech Morning en 2026-09-14T14:18:15.600Z A Billion-Dollar Bet on a Protein Most People Have Never Heard Of https://biotechmorning.com/news/cellectis-abandons-allogeneic-car-t-pivots-in-vivo Biotech Morning en 2026-09-14T14:17:34.200Z The Company That Pioneered Off-the-Shelf CAR-T Just Walked Away From It https://biotechmorning.com/news/jj-amivantamab-papillon-os-catch Biotech Morning en 2026-09-14T14:16:45.332Z J&J Says This Lung Cancer Combo Delivers Nearly 3 Years of Survival. There's a Catch. https://biotechmorning.com/news/lsd-pill-three-phase-3-wins-psychedelic-medicine Biotech Morning en 2026-09-14T14:15:53.507Z An LSD Pill Just Went 3-for-3 in the Biggest Test of Psychedelic Medicine https://biotechmorning.com/news/brain-cancer-first-real-map-pixclara-fda Biotech Morning en 2026-09-14T14:15:08.366Z Brain Cancer Just Got Its First Real Map https://biotechmorning.com/news/vyriad-in-vivo-car-t-first-patient Biotech Morning en 2026-09-14T14:14:24.602Z What If Your Body Could Build Its Own Cancer-Killing Cells? https://biotechmorning.com/news/gilead-trodelvy-lung-cancer-trial-failure Biotech Morning en 2026-09-14T14:13:38.286Z Gilead's Lung Cancer Moonshot Just Crashed Back to Earth https://biotechmorning.com/news/lenacapavir-purpose-2-hiv-prevention-results Biotech Morning en 2026-09-14T14:12:42.202Z Two Shots a Year. Two Infections Out of 2,180 People. https://biotechmorning.com/news/stealth-bio-barth-syndrome-fda-approval Biotech Morning en 2026-09-14T14:11:57.684Z The Drug That Failed Its Big Test and Still Got FDA Approval